0

CONZIP از شرکت CIPHER PHARMS INC

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CONZIP از شرکت CIPHER PHARMS INC

New Drug Application (NDA): 022370

Company: CIPHER PHARMS INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CONZIP TRAMADOL HYDROCHLORIDE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

None

Yes Yes
CONZIP TRAMADOL HYDROCHLORIDE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

None

Yes No
CONZIP TRAMADOL HYDROCHLORIDE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

None

Yes No
CONZIP TRAMADOL HYDROCHLORIDE 150MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/07/2010 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Label (PDF)

Letter (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022370s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022370s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022370s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022370s000_tramadol_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/04/2021 SUPPL-20 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022370s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022370Orig1s020ltr.pdf

10/07/2019 SUPPL-18 Labeling-Medication Guide, Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022370s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022370Orig1s018ltr.pdf

09/18/2018 SUPPL-17 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022370s016s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022370Orig1s016s017ltr.pdf

09/18/2018 SUPPL-16 REMS – PROPOSAL – D-N-A

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022370s016s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022370Orig1s016s017ltr.pdf

08/29/2017 SUPPL-15 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022370s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022370Orig1s015ltr.pdf

12/16/2016 SUPPL-14 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022370s012s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022370Orig1s012,s014ltr.pdf

07/09/2015 SUPPL-13 Manufacturing (CMC)

Label is not available on this site.

12/16/2016 SUPPL-12 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022370s012s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022370Orig1s012,s014ltr.pdf

01/20/2015 SUPPL-11 Manufacturing (CMC)

Label is not available on this site.

01/05/2015 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

08/13/2013 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

04/09/2013 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/04/2021 SUPPL-20

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022370s020lbl.pdf
10/07/2019 SUPPL-18

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022370s018lbl.pdf
10/07/2019 SUPPL-18

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022370s018lbl.pdf
09/18/2018 SUPPL-17

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022370s016s017lbl.pdf
09/18/2018 SUPPL-16

REMS – PROPOSAL – D-N-A

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022370s016s017lbl.pdf
08/29/2017 SUPPL-15

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022370s015lbl.pdf
12/16/2016 SUPPL-14

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022370s012s014lbl.pdf
12/16/2016 SUPPL-12

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022370s012s014lbl.pdf
05/07/2010 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022370s000lbl.pdf
بخوانید  CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER از شرکت TEVA PHARMS
برچسب‌ها:

نظرات کاربران